Sampath Srisailam

Associate Research Director at Syngene International Limited

Currently heading, Manufacturing Sciences and Technology (MSAT), in Syngene International Limited, Bangalore, India.  Earned his Ph.D. in structural biology and possesses 18+ years of experience in biopharmaceutical development. Published several publications in peer reviewed international scientific journals.
Led analytical method development and Physico-Chemical characterization for eight biosimilar molecules including the world’s first biosimilar antibody, Rituximab.  Led teams in creating CMC sections of dossiers for several biosimilars.  As a Quality Assurance lead, ensured appropriate quality systems in drug substance manufacturing of biosimilars and successfully completed EU-QP audits without major observations.